ASTRAZENECA PLC (AZN)
Clinical trial NCT07141277 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-03-20 3. primary completion date: 2026-06-30 → 2026-03-20 4. enrollment: 4000 → 4060 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical